Main Details Additional Contacts
New Registration
All registered participants who require programme additions/changes please contact admin direct

Please provide a minimum of Default and Invoice Contact (mandatory). If you wish to add further Trial contacts please do so in the space below or on the 'Additional Contacts' tab above.

      Default Contact   Trial Contact   Invoice Contact
  Tel No:        
  Fax No:        
  Notify contact of genetic trial and report issues:        
If you do not select ‘Courier Services Required’ samples will be sent by standard post. When samples are dispatched by standard post we are unable to track samples or troubleshoot delivery issues. Samples sent by standard shipping may take 2-3 weeks to be delivered and it is the participants responsibility to request repeat samples if delivery is not made or delayed.
  Order Number:  
We would like to join the following programmes. Please tick as appropriate
Flow Cytometry Programmes
  CD34+ Stem Cell Enumeration    
  Immune Monitoring  
  Leukaemia Diagnostic Interpretation (Parts 1 & 2)    
  Leukaemia Diagnostic Interpretation (Part 2 Individual)    
  Leukaemia Diagnostic Interpretation (Part 2 Institute)    
  Low Level Leucocyte Enumeration  
  Measurable Residual Disease for ALL by Flow Cytometry    
  Paroxysmal Nocturnal Haemoglobinuria    
  Cerebrospinal Fluid (CSF) Immunophenotyping (Not Accredited)    
  Haematological Malignancy Bone Marrow Aspirate Assessment (Not Accredited)  
  Measurable Residual Disease for AML by Flow Cytometry (Not Accredited)    
  Measurable Residual Disease for CLL by Flow Cytometry (Not Accredited)    
  Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (Not Accredited)    
Molecular Haemato-Oncology Programmes
  BCR::ABL1 and AML Translocation Identification    
  BCR::ABL1 Kinase Domain Variant (Mutation) Status    
  BCR::ABL1 Major Quantification    
  BCR::ABL1 Minor Quantification    
  BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia    
  FLT3 Mutation Status    
  IG/TCR Clonality Status    
  KIT p.Asp816Val (D816V) Mutation Status for Mast Cell Disease    
  Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinaemia    
  NPM1 Mutation Status    
  Paediatric Acute Leukaemia Translocations    
  Post-Stem Cell Transplant Chimerism Monitoring    
  Lymphoid Gene Panels (Not Accredited)    
  Measurable Residual Disease for AML by Molecular Methods (Not Accredited)  
  Measurable Residual Disease for Lymphoid Neoplasms by Molecular Methods (Not Accredited)    
  Myeloid Gene Panels (Pilot - Not Accredited)    
  Myeloproliferative Neoplasms Diagnostic Testing (Not Accredited)*    
       All contact details provided to UK NEQAS for Leucocyte Immunophenotyping, directly or through your distributor, will be used for the purposes of providing EQA Services. UK NEQAS for Leucocyte Immunophenotyping has the right to keep contact names in our secure databases for medico-legal purposes and cannot be removed. Do not submit any individuals contact details unless you have their express permission to do so.
       *The JAK2 p.V617F Mutation Status and Myeloproliferative Neoplasms Diagnostic Testing programmes have now been merged and include testing of JAK2 p.V617F, JAK2 exon 12, CALR and MPL. Please note, only the JAK2 p.Val617F aspect of testing is currently accredited. We are working towards accreditation for the other markers.